SYNERGISTISK FARMACEUTISK PRAEPARAT TIL BEHANDLING AF DEPRESSIVE SYMTOMER, FREMGANGSMAADE TIL DETS FREMSTILLING OG ANVENDELSE AF DEN FREMSTILLEDE BLANDING TIL PRAEPARATETS FREMSTILLING

SYNERGISTISK FARMACEUTISK PRAEPARAT TIL BEHANDLING AF DEPRESSIVE SYMTOMER, FREMGANGSMAADE TIL DETS FREMSTILLING OG ANVENDELSE AF DEN FREMSTILLEDE BLANDING TIL PRAEPARATETS FREMSTILLING

The invention relates to a synergistic pharmaceutical composition, which comprises as an active ingredient a combination of 1-phenylalanine and (-)-deprenyl [(-)-N-(1-phenylisopropyl)-N-methyl-N-propinylamine hydrochloride] and optionally carbidopa [3-(3,4-dihydroxyphenyl)-2-hydrazino-2--methyl-prop...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KNOLL, JOZSEF, BIRKMAYER, WALTER, ECSERY, ZOLTAN, MARTON, JENO, KALLOY, KATALIN
Format: Patent
Sprache:dan
Schlagworte:
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to a synergistic pharmaceutical composition, which comprises as an active ingredient a combination of 1-phenylalanine and (-)-deprenyl [(-)-N-(1-phenylisopropyl)-N-methyl-N-propinylamine hydrochloride] and optionally carbidopa [3-(3,4-dihydroxyphenyl)-2-hydrazino-2--methyl-propionic acid monohydrate] or benzerazide [N-(DL--seryl)-N'-(2,3,4-trihydroxybenzyl)-hydrazinel in association with conventional inert, non-toxic solid or liquid pharmaceutical carriers. The invention further relates to the preparation of these compositions and to the use thereof for the treatment of depressive symptoms.